Case study highlights Parkinson’s-like toxicity after BCMA-directed CAR T-cell therapy
Clinicians treating patients with CAR T cells have become adept at identifying and treating acute neurotoxicity, a common adverse event associated with the therapy. Researchers at Mount Sinai published a case study in Nature Medicine of a patient who developed a neurocognitive, hypokinetic movement disorder with features of Parkinson’s disease after receiving the CAR-T therapy […]
